Skip to main content
Clinical Trials/IRCT20200127046282N33
IRCT20200127046282N33Not yet recruitingPhase 1

Investigating the effectiveness of the combination therapy of CO2 fractional laser and conditioned medium derived from foreskin fibroblast cells in the treatment of burn scars compared to CO2 fractional laser alone : Phase 1 clinical trial

Tehran University of Medical Sciences0 sites18 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Enrollment
18

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
All

Inclusion Criteria

  • Patients with skin type 1-4
  • Patients with atrophic burn scars in more than one organ from 5 years ago to 3 months ago

Exclusion Criteria

  • Age under 18 years
  • Patients who have received laser treatment in the last three months
  • Patients with active colloidal scar or active skin lesion at the injection site
  • Patients with coagulation and platelet disorders
  • Patients with a history of underlying disease such as diabetes and autoimmune connective tissue disease that affect wound healing
  • Patients with active viral infections
  • Patients with a history of anticoagulants
  • History of malignancy or receiving chemotherapy
  • Pregnancy and lactation

Investigators

Similar Trials